Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roper Technologies (ROP) Cash & Equivalents (2016 - 2026)

Roper Technologies (ROP) has disclosed Cash & Equivalents for 18 consecutive years, with $382.9 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 2.71% year-over-year to $382.9 million; the TTM value through Mar 2026 reached $382.9 million, up 2.71%, while the annual FY2025 figure was $297.4 million, 58.02% up from the prior year.
  • Cash & Equivalents hit $382.9 million in Q1 2026 for Roper Technologies, up from $297.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.2 billion in Q1 2022 and bottomed at $188.2 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $830.9 million, with a median of $320.0 million recorded in 2025.
  • Year-over-year, Cash & Equivalents soared 878.1% in 2022 and then tumbled 84.19% in 2023.
  • Roper Technologies' Cash & Equivalents stood at $432.9 million in 2022, then plummeted by 50.5% to $214.3 million in 2023, then fell by 12.18% to $188.2 million in 2024, then skyrocketed by 58.02% to $297.4 million in 2025, then increased by 28.75% to $382.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $382.9 million, $297.4 million, and $320.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.